ConductScience.org, home

Paper39563449

Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus.

Chen X and 7 others. Arthritis Res Ther, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus. Papers, record 39563449. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39563449

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus.
PubMed
Journal
Arthritis Res Ther
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.12, provisional
iCite
Revised in PubMed
2026-06-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXin
2Zhu LLingjiang
3Xu JJieying
4Cheng QQi
5Dong YYuanji
6Xie YYifan
7Hua LLi
8Du YYan

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lupus Erythematosus, SystemicMajor topic
SemaphorinsMajor topic
Th17 CellsMajor topic
Cell DifferentiationMajor topic
Proto-Oncogene Proteins c-aktMajor topic
TOR Serine-Threonine KinasesMajor topic
Phosphatidylinositol 3-KinasesMajor topic
Humans
Female
Adult
Male
Signal Transduction
Nerve Tissue Proteins
Middle Aged
Young Adult
Cells, Cultured
Flow Cytometry
Blotting, Western
Enzyme-Linked Immunosorbent Assay

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No.2024ZL099The Traditional Chinese Medicine Science and Technology Project of Zhejiang ProvincePubMed
No. 82271817National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123913957Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.J Immunol2013https://conductscience.org/library/papers/23913957PubMed
232917979IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis.Cell Mol Immunol2021https://conductscience.org/library/papers/32917979PubMed
315218527Plexin-B3 is a functional receptor for semaphorin 5A.EMBO Rep2004https://conductscience.org/library/papers/15218527PubMed
429213125The role of semaphorins in immune responses and autoimmune rheumatic diseases.Nat Rev Rheumatol2018https://conductscience.org/library/papers/29213125PubMed
535059729Extracellular domain of semaphorin 5A serves a tumor‑suppressing role by activating interferon signaling pathways in lung adenocarcinoma cells.Int J Oncol2022https://conductscience.org/library/papers/35059729PubMed
627306639Systemic lupus erythematosus.Nat Rev Dis Primers2016https://conductscience.org/library/papers/27306639PubMed
733581650Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function.Biomed Pharmacother2021https://conductscience.org/library/papers/33581650PubMed
89324032Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1997https://conductscience.org/library/papers/9324032PubMed
936087549Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.Biomaterials2022https://conductscience.org/library/papers/36087549PubMed
1034540858The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis.Front Med (Lausanne)2021https://conductscience.org/library/papers/34540858PubMed
1130654587Role of Semaphorins in Immunopathologies and Rheumatic Diseases.Int J Mol Sci2019https://conductscience.org/library/papers/30654587PubMed
123114409In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.J Exp Med1987https://conductscience.org/library/papers/3114409PubMed
1332528480T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus.Front Immunol2020https://conductscience.org/library/papers/32528480PubMed
1433200217Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.Rheumatology (Oxford)2021https://conductscience.org/library/papers/33200217PubMed
1521835343Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function.Neuron2011https://conductscience.org/library/papers/21835343PubMed
1630972208miR-125a-3p decreases levels of interlukin-17 and suppresses renal fibrosis via down-regulating TGF-β1 in systemic lupus erythematosus mediated Lupus nephritic mice.Am J Transl Res2019https://conductscience.org/library/papers/30972208PubMed
1724683191Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.J Immunol2014https://conductscience.org/library/papers/24683191PubMed
1817538187Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice.J Am Soc Nephrol2007https://conductscience.org/library/papers/17538187PubMed
1935872102Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.J Autoimmun2022https://conductscience.org/library/papers/35872102PubMed
2031791181Interleukin-17 and lupus: enough to be a target? For which patients?Lupus2020https://conductscience.org/library/papers/31791181PubMed

See all 40 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42075897PPAR-α Agonist Suppresses Expression of Immune Mediators in B Cells in a Murine Model of Systemic Lupus Erythematosus.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075897PubMed
41893339Serum Semaphorin Alterations in Psoriasis: Links to Metabolic Status Rather than Disease Severity.Metabolites2026https://conductscience.org/library/papers/41893339PubMed
41164222The Function of the TGFβ Signaling Pathway in Connective Tissue Diseases: From Biology to Clinical Application.J Inflamm Res2025https://conductscience.org/library/papers/41164222PubMed
41113857Expression levels of interleukin-17 and interferon-γ in peripheral blood and relationship with thyroid function in patients with Hashimoto's thyroiditis.Front Mol Biosci2025https://conductscience.org/library/papers/41113857PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39563449

GET https://conductscience.org/api/papers/v1/39563449/references?page=2